Yet Another Bulletin Board

Welcome, Guest. Please Login or Register.
Oct 4th, 2024, 6:12pm

Home Home Help Help Search Search Members Members Member Map Member Map Login Login Register Register
Clusterheadaches.com Message Board « Zyprexa (olanzapine)--for Chronic headache »


   Clusterheadaches.com Message Board
   New Message Board Archives
   Medications, Treatments, Therapies 2002
(Moderator: DJ)
   Zyprexa (olanzapine)--for Chronic headache
« Previous topic | Next topic »
Pages: 1  Reply Reply Notify of replies Notify of replies Send Topic Send Topic Print Print
   Author  Topic: Zyprexa (olanzapine)--for Chronic headache  (Read 205 times)
Bob_Johnson
New Board Hall of Famer
USA 
*****





   
Email

Gender: male
Posts: 1796
Zyprexa (olanzapine)--for Chronic headache
« on: Sep 2nd, 2002, 8:37am »
Quote Quote Modify Modify

Title: Olanzapine Effective For Chronic Headache But Should Be Used With Caution
 
Journal of Head and Face Pain 20022 vol42 No 6 pp 515-518 "Olanzapine in the Treatment of Refractory Migraine and Chronic Daily Headache"
08/30/2002 11:45:43 AM
By Veronica Rose
 
 
Patients with refractory headache, including those who failed to benefit from other prophylactic agents, may be effectively treated with olanzapine. Caution is advised, however, for its use among patients who also have mania, bipolar disorder, psychotic depression or those previously treated successfully with other neuroleptic medications. This new antipsychotic drug, has pharmacologic properties suggesting it might be an effective therapy for headaches. In addition, it has a low propensity for the induction of extrapyramidal reactions or tardive dyskinesia. Subsequently, American researchers at the Thomas Jefferson University Hospital in Philadelphia, Pennsylvania, assessed the therapeutic value of olanzapine for chronic refractory headache in 50 patients for the minimum of three months. They had all received at least four preventive medications, which failed. Patients were given olanzapine at varying doses from 2.5 to 35 mg daily. Nineteen were given 5mg daily while 17 received 10mg. Response from this therapy provided a statistically significant decrease in the number of headache days relative to baseline. This ranged from 27.5 ± 4.9 before treatment, to 21.1 ± 10.7 after therapy. Researchers also established that the degree of headache severity differed significantly from pretreatment levels (8.7 ± 1.6) and post therapy (2.2 ± 2.1).  
 
 
 
IP Logged

Bob Johnson
Pages: 1  Reply Reply Notify of replies Notify of replies Send Topic Send Topic Print Print

« Previous topic | Next topic »


Clusterheadaches.com Message Board » Powered by YaBB 1 Gold - SP 1.3.1!
YaBB © 2000-2003. All Rights Reserved.


©1998-2010 Web Vision Enterprises All rights reserved. All information on this site is protected by international copyright laws. You may not re-distribute any information from this site without written permission from Web Vision Enterprises and the webmaster of this site. Violators will be prosecuted.
You may view our privacy policy and financial disclosure statement here

test rss